Abstract
Classic teaching recommends the addition of an immunosuppressive agent, such as azathioprine, to systemic corticosteroids as the initial treatment of bullous pemphigoid. To date only two controlled studies have looked at adjuvant therapy in the treatment of this disease: one found azathioprine to be steroid-sparing, and the other found the same benefit with plasma exchange. However, neither study was …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
